94 related articles for article (PubMed ID: 33419825)
1. Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study.
Vanni G; Materazzo M; Dauri M; Farinaccio A; Buonomo C; Portarena I; Pellicciaro M; Legramante JM; Rizza S; Chiaramonte C; Bellia A; Grande M; Potenza S; Sbordone FP; Perrone MA; Grimaldi F; Chiocchi M; Buonomo OC
Anticancer Res; 2021 Jan; 41(1):307-316. PubMed ID: 33419825
[TBL] [Abstract][Full Text] [Related]
2. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
Xu Y; Qian Y; Gu Q; Tang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictive value of hypocalcemia in severe COVID-19 patients.
Liu J; Han P; Wu J; Gong J; Tian D
J Infect Public Health; 2020 Sep; 13(9):1224-1228. PubMed ID: 32622796
[TBL] [Abstract][Full Text] [Related]
5. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
8. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
[TBL] [Abstract][Full Text] [Related]
10. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
11. The value of clinical parameters in predicting the severity of COVID-19.
Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia.
Masotti L; Grifoni E; Pelagalli G; Cioni E; Mattaliano C; Cioffi E; Maggi F; Pinto G; Madonia EM; Micheletti I; Gelli AMG; Ciambotti B; Mannucci A; Bello R; Cei F; Dolenti S; Tarquini R; Montenora I; Spina R; Vanni S
Int Immunopharmacol; 2022 Feb; 103():108435. PubMed ID: 34920336
[TBL] [Abstract][Full Text] [Related]
13. A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.
Huang Y; Lyu X; Li D; Wang L; Wang Y; Zou W; Wei Y; Wu X
PLoS One; 2020; 15(11):e0242045. PubMed ID: 33166991
[TBL] [Abstract][Full Text] [Related]
14. [Value of interleukin-6 and CD4
Shi X; Qin L; Yang L; Bai W; Jing L; Mei K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1165-1170. PubMed ID: 33198856
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
[TBL] [Abstract][Full Text] [Related]
16. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
Fei M; Tong F; Tao X; Wang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
[TBL] [Abstract][Full Text] [Related]
17. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.
Yao Y; Chen W; Wu X; Shen L; Shen L; Fu Y; Yang Q; Yao M; Zhou J; Zhou H
Clin Microbiol Infect; 2020 Oct; 26(10):1380-1385. PubMed ID: 32593742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
